A Prime Therapeutics analysis of real-world data has found that medical costs for patients taking GLP-1 drugs for obesity had increased by about $1,338 per member, compared with a matched control ...
GLP-1, a hormone naturally produced in the gut, plays a crucial role in regulating blood glucose levels and appetite.
Is 'nearshoring', the preference among pharma and biotech to move operations to the domestic markets versus outsourcing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results